The Cristian Rivera Foundation is pleased to announce that Dr. Mark Souweidane, leading pioneer of the DIPG clinical trials at Memorial Sloan Kettering Cancer Center and Weill Cornell Medical Center, has just operated on the trial’s second patient today, Tuesday, July 17th! This clinical trial has been making great strides in the battle against DIPG, providing hope for families who previously had none. Dr. Souweidane operated on the first patient of the trial on Monday, May 1st and the beautiful 4-year-old girl has been doing surprisingly well. We are so proud to have helped fund this groundbreaking clinical trial, one that we hope will lead to finding a cure for DIPG. Currently, DIPG is an incurable disease which claims the lives of 200-300 children between the ages of 1 and 9 in the United States each year, a statistic we hope to abolish in the future. Full Steam Ahead!
